a Department of Epidemiology , School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education , Shanghai , China.
b Department of Infectious Diseases Prevention, Suzhou Center for Disease Prevention and Control , Suzhou , China.
Hum Vaccin Immunother. 2018 Mar 4;14(3):630-636. doi: 10.1080/21645515.2017.1397868. Epub 2017 Dec 6.
We actively followed a cohort of nursery school children in Suzhou, China to assess the impact of vaccination with trivalent influenza vaccine on the prevention of influenza like illness (ILI).
We enrolled children aged 36 to 72 months from 13 nursery schools in Suzhou starting two weeks after vaccination during October 2015-February 2016. Every school-day, teachers reported the names of students with ILI to study clinicians, who collected the student's nasopharyngeal swab or throat swab, either at a study clinic or the child's home. Swabs were sent to the Suzhou Center for Disease Control and Prevention's laboratory for influenza testing by RT-PCR.
In total, 3278 children were enrolled; 83 (3%) were lost to follow-up, while 3195 (vaccinated: 1492, unvaccinated: 1703) were followed for 24 weeks. During the study, 40 samples tested positive; 17 in the vaccinated (B Victoria: 12; A(H1N1)pdm09: 5) and 23 in the unvaccinated group (B Victoria: 10; B Yamagata: 2; A(H1N1)pdm09: 11). The VE estimates were: 16% overall (95%CI:-58%,56%), 48% (-47%,84%) for influenza A(H1N1)pdm09, 43% (-650%,98%) for influenza B Yamagata, and -37% (-227%,42%) for influenza B Victoria. Data were analyzed by vaccinated and unvaccinated groups based on enrollees' vaccination records.
The VE for A(H1N1)pdm09 was moderate but not significant. Mismatching of B lineage may have compromised trivalent influenza vaccine effectiveness during the 2015-2016 influenza season among nursery school children in Suzhou, China. Additional larger studies are warranted to inform policy related to quadrivalent influenza vaccine licensure in China in the future.
我们积极随访了中国苏州的一个幼儿园队列,以评估接种三价流感疫苗对预防流感样疾病(ILI)的影响。
我们从苏州的 13 所幼儿园招募了 36 至 72 个月龄的儿童,从 2015 年 10 月至 2016 年 2 月,在接种后两周内开始。每个上学日,教师都会向研究临床医生报告 ILI 患儿的姓名,研究临床医生会从研究诊所或患儿家中采集患儿的鼻咽拭子或咽拭子。拭子通过实时聚合酶链反应(RT-PCR)被送往苏州疾病预防控制中心实验室进行流感检测。
共有 3278 名儿童入组;83 名(3%)失访,3195 名(接种组:1492 名,未接种组:1703 名)随访 24 周。在研究期间,有 40 个样本检测呈阳性;接种组 17 个(B Victoria:12 个;A(H1N1)pdm09:5 个),未接种组 23 个(B Victoria:10 个;B Yamagata:2 个;A(H1N1)pdm09:11 个)。疫苗效力估计值为:总体 16%(95%CI:-58%,56%),A(H1N1)pdm09 48%(-47%,84%),B Yamagata 43%(-650%,98%),B Victoria-37%(-227%,42%)。根据入组儿童的疫苗接种记录,按接种组和未接种组对数据进行分析。
A(H1N1)pdm09 的疫苗效力为中等,但无统计学意义。B 谱系不匹配可能降低了中国苏州幼儿园儿童在 2015-2016 流感季节三价流感疫苗的效力。未来需要进行更大规模的研究,为中国未来批准四价流感疫苗提供政策依据。